Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

NCT07197944 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Short Bowel Syndrome

Interventions

DRUG: Glepaglutide
OTHER: Placebo

Sponsor

Zealand Pharma